Intellia Therapeutics Inc
Ownership
Ownership Structure
Who owns Intellia Therapeutics Inc (NTLA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 95.7% of the shares are freely tradable; institutional investors hold 76.7%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Investment Management LLC | 10.35 | 14,509,247 | +2.1 | 03/31/2026 |
| BlackRock Inc | 8.67 | 12,155,806 | +18.3 | 03/31/2026 |
| State Street Corp | 4.94 | 6,922,676 | +7.8 | 03/31/2026 |
| D. E. Shaw & Co LP | 4.60 | 6,443,323 | +12.5 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 4.44 | 6,223,325 | +0.0 | 03/31/2026 |
| Two Sigma Investments LLC | 3.74 | 5,235,348 | +11.3 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.63 | 5,084,105 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Disruptive Innovation Full Composite | 7.94 | 11,126,474 | +19.5 | 06/30/2026 |
| ARK Innovation ETF | 6.90 | 9,667,941 | -0.6 | 08/31/2026 |
| State Street® SPDR® S&P® Biotech ETF | 4.32 | 6,058,629 | -1.1 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Leonard John M | President and CEO | 1,147,064 | 14,108,887 $ | Aug 21, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | Leonard John M | President and CEO | Sell | 2,785 | 13.00 | 36,205 |
| Aug 20, 2026 | Leonard John M | President and CEO | Sell | 19,890 | 12.60 | 250,614 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.